CD73 and Adenosine Receptor Signaling as a Potential Therapeutic Target in EGFR-Mutated NSCLC

被引：4
|
作者：
Pacheco, Jose M. [1 ]
Schenk, Erin L. [1 ]
机构：
[1] Univ Colorado, Dept Internal Med, Div Med Oncol, Ctr Canc, Anschutz Med Campus,1665 Aurora Court, Aurora, CO 80045 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 04期
基金：
美国国家卫生研究院;
关键词：
CELL LUNG-CANCER; PATHWAY;
D O I：
10.1016/j.jtho.2021.01.1623
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：509 / 511
页数：3
相关论文
共 50 条
  • [31] CD73 in hepatobiliopancreatic system: a potential target for immunotherapy and additional tool for the pathological diagnosis
    Sciarra, A.
    Monteiro, I.
    Menetrier-Caux, C.
    Caux, C.
    La Rosa, S.
    Romero, P.
    Sempoux, C.
    de Leval, L.
    VIRCHOWS ARCHIV, 2018, 473 : S124 - S124
  • [32] CD73 and PD-L1 as Potential Therapeutic Targets in Gallbladder Cancer
    Cao, Lu
    Bridle, Kim R.
    Shrestha, Ritu
    Prithviraj, Prashanth
    Crawford, Darrell H. G.
    Jayachandran, Aparna
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (03)
  • [33] Blockade pf CD73/adenosine axis improves the therapeutic efficacy of docetaxel in epithelial ovarian cancer
    Li, Hongmei
    Lv, Meihua
    Qiao, Baohua
    Li, Xia
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2019, 299 (06) : 1737 - 1746
  • [34] The extracellular adenosine metabolism by CD73: a new therapeutic approach for inflammation-associated vascular diseases?
    Massold, Timo
    Simon, Florian
    Floegel, Ulrich
    Temme, Sebastian
    Bouvain, Pascal
    GEFASSCHIRURGIE, 2024, 29 (06): : 364 - 369
  • [35] Blockade pf CD73/adenosine axis improves the therapeutic efficacy of docetaxel in epithelial ovarian cancer
    Hongmei Li
    Meihua Lv
    Baohua Qiao
    Xia Li
    Archives of Gynecology and Obstetrics, 2019, 299 : 1737 - 1746
  • [36] DEEP SEQUENCING OF HCC ENDOTHELIUM REVEALS AN ACTIVE ROLE IN IMMUNOSUPPRESSION AND HIGHLIGHTS THE ECTO NUCLEOTIDASE CD73 AS A POTENTIAL THERAPEUTIC TARGET
    Faulkes, Rosemary
    O'Rourke, Joanne
    Cain, Owen
    Patten, Daniel
    Wilkinson, Alex
    Shah, Tahir
    Weston, Christopher
    GUT, 2021, 70 : A1 - A1
  • [37] RICTOR signaling modulates the activity of EGFR tyrosine kinase inhibitors (TKI) in EGFR-mutated non-small cell lung cancer (NSCLC)
    Fan, Ni
    Zou, Yiyu
    Halmos, Balazs
    Perez-Soler, Roman
    Cheng, Haiying
    CANCER RESEARCH, 2019, 79 (13)
  • [38] The Therapeutic Potential of the Restoration of the p53 Protein Family Members in the EGFR-Mutated Lung Cancer
    Fregni, Matilde
    Ciribilli, Yari
    Zawacka-Pankau, Joanna E.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (13)
  • [39] Different Epidermal Growth Factor Receptor Inhibitor Generations Plus Antiangiogenic for EGFR-Mutated NSCLC: A Meta-Analysis
    Al-Kraimeen, L.
    Ababneh, O.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S447 - S447
  • [40] Effects of AMP on core body temperature in A1 adenosine receptor and CD73 knockout mice
    Eisner, Christoph
    Kim, Soo Mi
    Briggs, Josie
    Schnermann, Jurgen
    FASEB JOURNAL, 2007, 21 (06): : A1312 - A1312
12345